Glycerol tight market business investment continued to rise
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
You May Interested In
2026-08-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Is Glycerol Water Soluble? An Oddball Solution For Hydration
-
Market Analysis - Weekly Report - February 14th to February 18th, 2022- Hot Products
-
Market Analysis- Weekly Report- November 1st to November 5th, 2021- Hot Products
-
BASF sends out a price increase letter again! MDI, glycerol, epoxy and many other raw materials have soared!
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
“An €8 Billion Loss, Yet a 25% Price Hike”: Wacker Chemie’s Contradictory Crisis—Survival Move or Desperate Gamble?
-
“Fluoro-Fiasco”? Sudden Full Shutdown of Huayi Group’s Fluorochemical Plant Sends Shockwaves Through PVDF Markets
Recommend Reading
-
“The C Empire Unites!”: Wanhua Chemical’s $26.5 Billion Bet on Ethylene Integration—Is It Becoming China’s BASF or the New Global Olefins Overlord?
-
Europe’s Chemical Industry Sounds the “Shutdown Alarm”: It’s Not Just a Few Plants at Risk—The Entire Industrial Chain Is Shaking
-
AkzoNobel Completes Sale of AkzoNobel India Limited to JSW Group
-
Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus
-
Brazil’s SISPA Platform Signals a New Phase in Pesticide Registration
-
EVA Market Conditions in China Show Slight Improvement in August
-
Strong Supply and Weak Demand Lead to Lower Dichloromethane Prices in China
-
This Week's Styrene Market Slightly Declined (9.8-9.12) in China
-
August Hydrofluoric Acid Market Prices Weakly Decline
-
This Week TDI Market Stopped Falling and Rose (9.8-9.12)